About 193 results

ALLMedicine™ Short-bowel Syndrome Center

Research & Reviews  68 results

Indications, functional and quality of life outcomes of new pouch creation during re-do...
Surgery Esen E, Kirat HT et. al.

Jul 18th, 2021 - Salvage of the existing ileal pouch is favored during re-do ileal pouch anal anastomosis if the pouch is not damaged after pelvic dissection and there are no other mechanical reasons that may necessitate construction of a new pouch. Excision of th...

Twelve-year outcomes of intestinal failure-associated liver disease in children with sh...
JPEN. Journal of ParEnteral and Enteral Nutrition; Torres C, Badalyan V et. al.

Apr 2nd, 2021 - Our aim was to analyze the outcomes in children with short-bowel syndrome (SBS), parenteral nutrition dependence (PND), and intestinal failure-associated liver disease (IFALD) treated in our Intestinal Rehabilitation Program (IRP) during 2007-2018...

Congenital Short-Bowel Syndrome: Clinical and Genetic Presentation in China.
JPEN. Journal of ParEnteral and Enteral Nutrition; Wang Y, Chen S et. al.

Jan 20th, 2021 - Congenital short-bowel syndrome (CSBS) is a rare disorder characterized by retardation of intestinal development. However, it is still not well recognized at present. In this study, the etiological, clinical, and genetic characteristics of CSBS in...

An overview of the current management of short-bowel syndrome in pediatric patients.
https://doi.org/10.1007/s00595-020-02207-z 10.1016/j.jpeds.2015.03.040 10.1016/j.jpedsurg.2004.01.036 10.1097/MPG.0000000000001722 10.1136/archdischild-2016-311765 10.2147/JMDH.S236130 10.1016/j.jpedsurg.2009.01.031 10.1053/j.sempedsurg.2018.07.009 10.1053/j.gastro.2005.12.002 10.1016/S0016-5085(03)70064-X 10.1016/S1521-6918(03)00099-4 10.3390/nu12010177 10.1097/01.mpg.0000181841.07090.f4 10.1016/j.jpedsurg.2016.09.037 10.1053/spsu.2001.22384 10.1016/j.nut.2004.10.003 10.1016/j.clnu.2012.09.007 10.1016/j.jada.2009.12.001 10.1067/mpd.2001.114481 10.1016/S1521-6918(03)00082-9 10.1038/ejcn.2011.26 10.1016/j.jpedsurg.2012.03.019 10.1016/j.jpedsurg.2016.02.025 10.1016/j.jpedsurg.2015.03.018 10.1016/j.jhin.2006.01.009 10.1111/ped.14096 10.1007/s00383-016-3933-y 10.1016/j.jpedsurg.2019.09.071 10.1016/j.jpedsurg.2015.10.027 10.1592/phco. 10.1542/peds.2005-2662 10.1002/jpen.1692 10.1177/0148607111413598 10.1177/0884533613485882 10.1002/jpen.1809 10.1016/j.jpeds.2009.12.008 10.1111/j.1365-2036.2011.04826.x 10.1007/s11894-016-0511-3 10.1097/01.inf.0000154588.79356.e6 10.1097/00005176-200404000-00017 10.1007/s00467-003-1235-9 10.1007/s00467-011-1895-9 10.1007/s00774-009-0140-0 10.1159/000350616 10.1177/0148607114531046 10.1080/003655202317316006 10.1053/j.sempedsurg.2018.07.008 10.1139/y03-107 10.1097/MED.0000000000000120 10.1002/jpen.1690 10.1002/jpen.1853 10.1152/ajpgi.00281.2016 10.1016/S0022-3468(80)80005-4 10.1053/j.sempedsurg.2014.09.010 10.1097/MPG.0b013e318230c27e 10.1055/s-2008-1072258 10.1067/j.cpsurg.2011.10.002 10.1053/jpsu.2003.50073 10.1016/j.jamcollsurg.2012.12.018 10.1007/s00383-019-04468-3 10.1007/s11605-014-2577-2 10.1016/j.transproceed.2018.03.067 10.1111/ajt.13147 10.1097/MOT.0000000000000514 10.1097/TP.0000000000003065 10.1097/MOT.0000000000000736 10.1111/petr.13580 10.1053/j.sempedsurg.2017.07.007 10.1016/S0022-3468(00)90045-9 10.1002/jpen.1811 10.1177/0148607117695251 10.1007/s00595-017-1534-6 10.1001/jamasurg.2013.4332 10.1097/SLA.0000000000002602 10.1002/jpen.1691 10.1053/j.sempedsurg.2017.09.006 10.1097/MPG.0000000000002500
Surgery Today; Muto M, Kaji T et. al.

Jan 20th, 2021 - Short-bowel syndrome (SBS) is defined as a state of malabsorption after resection or loss of a major portion of the bowel due to congenital or acquired factors. This article presents an overview on the recent management of pediatric SBS. The pedia...

What is the optimal lipid emulsion for preventing intestinal failure-associated liver d...
Pediatric Surgery International; Machigashira S, Kaji T et. al.

Jan 4th, 2021 - Composite lipid emulsion (CLE) has been used for intestinal failure-associated liver disease (IFALD) to compensate for the disadvantages of soybean oil lipid emulsion (SOLE) or fish oil lipid emulsion (FOLE). However, the influence of its administ...

see more →

Clinicaltrials.gov  1 results

Regional Blood Saturation Levels in Gastroschisis

May 23rd, 2018 - Gastroschisis is one of the most common neonatal surgical conditions, and is increasing in incidence. Postnatal bowel ischemia leading to necrosis, bowel loss and short-bowel syndrome, occurs in a few instances, with significant impact. Intestinal...

see more →

News  8 results

Obeticholic acid fails to prevent liver damage in an animal model of short-bowel syndrome
Heidi Splete, MDedge News

Jun 25th, 2017 - Obeticholic acid failed to prevent the development of short-bowel syndrome–associated liver disease in a preliminary study using piglet models. The findings were published in the July issue of Cellular and Molecular Gastroenterology and Hepatology.

Unhealthy Attraction: Revisiting the Risks of Magnet Ingestion in Kids, as Product Recall Fails

May 12th, 2017 - Popular Toys With Overlooked Risks In a previous Medscape article, we related our concern that popular adult novelty items containing neodymium magnets (so-called "supermagnets") present an underappreciated danger to children. At that time, severa...

Update on the management of intestinal failure
Shishira Bharadwaj, MD, Parul Tandon, DO et. al.

Nov 1st, 2016 - Intestinal failure, the inability of the gut to maintain nutritional homeostasis,1 is a complication of vascular thrombosis, inflammatory bowel disease, radiation enteritis, obstruction, and other conditions, and of removing segments of the small.

Dermatitis in an intestinal transplant candidate
Sarah Taimur, MD, Lucileia Johnson, MD

Feb 1st, 2013 - A 36-year-old woman on total parenteral nutrition because of short-bowel syndrome presented with a 2-week history of skin lesions on the face, arms, and legs, but no fever. Examination revealed prominent vesicular lesions on the left arm (Figure 1.

Teduglutide Cuts Parenteral Nutrition Needs in Short-Bowel Syndrome
Patrice Wendling

May 27th, 2011 - CHICAGO – Phase III data from a randomized, placebo-controlled trial indicate that the novel agent teduglutide reduces the need for parenteral support in patients with short-bowel syndrome. At week 20 and week 24, 63% of patients who were randomiz.

see more →